Published On: Wed, Oct 19th, 2016

INC Research Holdings, Inc. (NASDAQ:INCR) Latest Broker Coverage


A number of investment brokers have recently updated their price targets on shares of INC Research Holdings, Inc. (NASDAQ:INCR).

Most recent broker ratings

09/07/2016 – INC Research Holdings, Inc. had its “conviction buy” rating reiterated by analysts at Goldman Sachs. They now have a USD 82 price target on the stock.

08/17/2016 – INC Research Holdings, Inc. had its “buy” rating reiterated by analysts at Jefferies. They now have a USD 55 price target on the stock.

06/20/2016 – Credit Suisse began new coverage on INC Research Holdings, Inc. giving the company a “outperform” rating. They now have a USD 51 price target on the stock.

05/03/2016 – INC Research Holdings, Inc. was downgraded to “neutral” by analysts at Robert W. Baird. They now have a USD 51 price target on the stock.

03/24/2016 – JP Morgan began new coverage on INC Research Holdings, Inc. giving the company a “overweight” rating. They now have a USD 47 price target on the stock.

11/18/2015 – SunTrust began new coverage on INC Research Holdings, Inc. giving the company a “buy” rating. They now have a USD 56 price target on the stock.

10/21/2015 – Avondale Partners began new coverage on INC Research Holdings, Inc. giving the company a “market perform” rating. They now have a USD 42 price target on the stock.

04/28/2015 – INC Research Holdings, Inc. had its “outperform” rating reiterated by analysts at William Blair.

03/31/2015 – Raymond James began new coverage on INC Research Holdings, Inc. giving the company a “outperform” rating. They now have a USD 37 price target on the stock.

02/27/2015 – INC Research Holdings, Inc. was upgraded to “outperform” by analysts at Zacks. They now have a USD 33.2 price target on the stock.

01/08/2015 – Keefe, Bruyette & Woods began new coverage on INC Research Holdings, Inc. giving the company a “hold” rating.

01/08/2015 – KeyBanc began new coverage on INC Research Holdings, Inc. giving the company a “hold” rating.

12/02/2014 – Wells Fargo began new coverage on INC Research Holdings, Inc. giving the company a “outperform” rating.

The share price of INC Research Holdings, Inc. (NASDAQ:INCR) was up +1.12% during the last day of trading, with a day high of 45.10. 331810 shares were traded during the last session.

The stock’s 50 day moving average is 44.36 and its 200 day moving average is 43.82. The stock’s market capitalization is 2.46B. INC Research Holdings, Inc. has a 52-week low of 34.19 and a 52-week high of 57.11.

INC Research Holdings, Inc. is a global contract research organization (CRO). The Company is focused on Phase I to Phase IV clinical development services for the biopharmaceutical and medical device industries. The Company operates through two segments: Clinical Development Services and Phase I Services. The Company’s Clinical Development Services segment offers all clinical development services, including full-service global studies, as well as ancillary services, such as clinical monitoring, investigator recruitment, patient recruitment, data management, study reports to assist customers with their drug development process, quality assurance audits and specialized consulting services. The Company’s Phase I Services segment focuses on clinical development services for Phase I trials, which include scientific exploratory medicine, first-in-human studies through proof-of-concept stages and support for Phase I studies in established compounds.